T1	Participants 380 426	A total of 119 women were taken into the study
T2	Participants 587 771	119 patients were randomized in three groups to receive daily fixed doses of 300 IU of rFSH (group A, n = 38), or 450 IU of rFSH (group B, n = 39), or 600 IU of rFSH (group C, n = 42).
